Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans

Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.

Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.

  1. Home
  2. Subjects
  3. virus
virus
Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor Activity
Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor Activity
The Scientist Creative Services Team in Collaboration with IsoPlexis | Apr 5, 2021
Katie McKenna will discuss how oncolytic viral therapy enhances CAR-T cell killing of cancer cells.
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
The Scientist Staff | Mar 31, 2021
Researchers identify signatures that predict how a person will respond to an immune system stimulus.
Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 29, 2021
Nicholas Hutchings will discuss how recombinant antibody technology can speed up the response to a pandemic.
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Jef Akst | Mar 24, 2021
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
Ebola Outbreak in Guinea Originated from Past Epidemic
Ebola Outbreak in Guinea Originated from Past Epidemic
Asher Jones | Mar 15, 2021
Genetic analyses suggest that the virus came from a patient who survived the 2013–2016 West African outbreak.
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
COVID-19 Vaccine Combos Aim to Boost Immunity
COVID-19 Vaccine Combos Aim to Boost Immunity
Asher Jones | Mar 9, 2021
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
Variant Found in Brazil Could Evade Immunity from Past Infection
Variant Found in Brazil Could Evade Immunity from Past Infection
Lisa Winter | Mar 2, 2021
The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.